Skip to Content
You are currently on the new version of our website. Access the old version .

116 Results Found

  • Article
  • Open Access
40 Citations
5,982 Views
14 Pages

Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging

  • Kongzhen Hu,
  • Li Li,
  • Yong Huang,
  • Shimin Ye and ,
  • Jiawei Zhong,
  • Qingsong Yan,
  • Yuhua Zhong,
  • Lilan Fu,
  • Pengju Feng and
  • Hongsheng Li
  • + 5 authors+ 0 author

21 March 2022

Due to tumor heterogeneity and complex tumor–stromal interactions in multicellular systems, the efficiency of monospecific tracers for tumor diagnosis and therapy is currently limited. In light of the evidence of prostate-specific membrane anti...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
16 Citations
4,830 Views
13 Pages

[99mTc]Tc-iFAP Radioligand for SPECT/CT Imaging of the Tumor Microenvironment: Kinetics, Radiation Dosimetry, and Imaging in Patients

  • Luis Coria-Domínguez,
  • Paola Vallejo-Armenta,
  • Myrna Luna-Gutiérrez,
  • Blanca Ocampo-García and ,
  • Brenda Gibbens-Bandala,
  • Francisco García-Pérez,
  • Gerardo Ramírez-Nava,
  • Clara Santos-Cuevas and
  • Guillermina Ferro-Flores
  • + 4 authors+ 0 author

Tumor microenvironment fibroblasts overexpress the fibroblast activation protein (FAP). We recently reported the preclinical evaluation of [99mTc]Tc-iFAP as a new SPECT radioligand capable of detecting FAP. This research aimed to evaluate the kinetic...

(This article belongs to the Special Issue Tumor-Targeting Radioligands for Molecular Imaging and Therapy)
  • Article
  • Open Access
19 Citations
5,755 Views
18 Pages

Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy

  • Francesco Bartoli,
  • Philip Elsinga,
  • Luiza Reali Nazario,
  • Aureliano Zana and ,
  • Andrea Galbiati,
  • Jacopo Millul,
  • Francesca Migliorini,
  • Samuele Cazzamalli,
  • Dario Neri and
  • Paola Anna Erba
  • + 6 authors+ 1 author

2 August 2022

FAP-targeted radiopharmaceuticals represent a breakthrough in cancer imaging and a viable option for therapeutic applications. OncoFAP is an ultra-high-affinity ligand of FAP with a dissociation constant of 680 pM. OncoFAP has been recently discovere...

(This article belongs to the Special Issue Alliance of PET/SPECT Imaging and Drug Design/Discovery for the Development of Novel Diagnostic or Therapeutic Tools)
  • Article
  • Open Access
43 Citations
7,764 Views
18 Pages

Design, Synthesis and Preclinical Assessment of 99mTc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging

  • Diana Trujillo-Benítez,
  • Myrna Luna-Gutiérrez,
  • Guillermina Ferro-Flores,
  • Blanca Ocampo-García and ,
  • Clara Santos-Cuevas,
  • Gerardo Bravo-Villegas,
  • Enrique Morales-Ávila,
  • Pedro Cruz-Nova,
  • Lorenza Díaz-Nieto and
  • Laura Meléndez-Alafort
  • + 8 authors+ 3 authors

1 January 2022

Fibroblast activation protein (FAP) is expressed in the microenvironment of most human epithelial tumors. 68Ga-labeled FAP inhibitors based on the cyanopyrrolidine structure (FAPI) are currently used for the detection of the tumor microenvironment by...

(This article belongs to the Special Issue Technetium and Rhenium in Chemistry and Their Advanced Applications)
  • Article
  • Open Access
53 Citations
10,915 Views
19 Pages

Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging

  • Romana Meletta,
  • Adrienne Müller Herde,
  • Aristeidis Chiotellis,
  • Malsor Isa and ,
  • Zoran Rancic,
  • Nicole Borel,
  • Simon M. Ametamey,
  • Stefanie D. Krämer and
  • Roger Schibli
  • + 4 authors+ 0 author

27 January 2015

Research towards the non-invasive imaging of atherosclerotic plaques is of high clinical priority as early recognition of vulnerable plaques may reduce the incidence of cardiovascular events. The fibroblast activation protein alpha (FAP) was recently...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
187 Views
19 Pages

Emerging Role of FAP-Targeted PET Imaging in Assessing Fibroblast Activation in Cardiovascular Disorders: A Review

  • Jonathan Caba,
  • Jozefina Jamsran,
  • Asha Tannis,
  • Shifa Yadav and ,
  • Rabbiya Aslam,
  • Magdalena Kostkiewicz and
  • Katarzyna Holcman
  • + 2 authors+ 0 author

31 October 2026

Cardiovascular fibrosis is a dynamic process that involves fibroblast activation, extracellular matrix production, and myocardial remodeling. While it can damage the heart through an unregulated and progressive response, it is also an essential compo...

(This article belongs to the Special Issue State of the Art in Cardiac Imaging)
  • Article
  • Open Access
5 Citations
2,938 Views
19 Pages

68Ga-DOTA-D-Alanine-BoroPro Radiotracer for Imaging of the Fibroblast Activation Protein in Malignant and Non-Malignant Diseases

  • Diana Trujillo-Benítez,
  • Myrna Luna-Gutiérrez,
  • José G. Aguirre-De Paz,
  • Pedro Cruz-Nova and ,
  • Gerardo Bravo-Villegas,
  • Joel E. Vargas-Ahumada,
  • Paola Vallejo-Armenta,
  • Enrique Morales-Avila,
  • Nallely Jiménez-Mancilla and
  • Guillermina Ferro-Flores
  • + 9 authors+ 4 authors

Recently, we reported a new fibroblast activation protein (FAP) inhibitor radiopharmaceutical based on the 99mTc-((R)-1-((6-hydrazinylnicotinoyl)-D-alanyl) pyrrolidin-2-yl) boronic acid (99mTc-HYNIC-D-Alanine-BoroPro)(99mTc-HYNIC-iFAP) structure for...

(This article belongs to the Special Issue Recent Advances in Radiopharmaceutics, 2nd Edition)
  • Article
  • Open Access
38 Citations
8,290 Views
17 Pages

Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging

  • Arsyangela Verena,
  • Zhengxing Zhang,
  • Hsiou-Ting Kuo,
  • Helen Merkens and ,
  • Jutta Zeisler,
  • Ryan Wilson,
  • Shreya Bendre,
  • Antonio A. W. L. Wong,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 5 authors+ 0 author

21 January 2023

Tumor heterogeneity limits the efficacy and reliability of monospecific radiopharmaceuticals in prostate cancer diagnosis and therapy. To overcome this limitation and improve lesion detection sensitivity, we developed and evaluated three bispecific r...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
8 Citations
4,459 Views
14 Pages

Synthesis and Preclinical Evaluation of Novel 68Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging

  • Shreya Bendre,
  • Hsiou-Ting Kuo,
  • Helen Merkens,
  • Zhengxing Zhang and ,
  • Antonio A. W. L. Wong,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 2 authors+ 0 author

Fibroblast activation protein (FAP) is a membrane-tethered serine protease overexpressed in the reactive stromal fibroblasts of >90% human carcinomas, which makes it a promising target for developing radiopharmaceuticals for the imaging and therap...

(This article belongs to the Special Issue Novel Imaging Probes: From Design to Applications)
  • Article
  • Open Access
7 Citations
3,482 Views
14 Pages

Synthesis and Evaluation of 68Ga-Labeled (2S,4S)-4-Fluoropyrrolidine-2-Carbonitrile and (4R)-Thiazolidine-4-Carbonitrile Derivatives as Novel Fibroblast Activation Protein-Targeted PET Tracers for Cancer Imaging

  • Shreya Bendre,
  • Zhengxing Zhang,
  • Nadine Colpo,
  • Jutta Zeisler and ,
  • Antonio A. W. L. Wong,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 2 authors+ 0 author

14 April 2023

Fibroblast activation protein α (FAP-α) is a cell-surface protein overexpressed on cancer-associated fibroblasts that constitute a substantial component of tumor stroma and drive tumorigenesis. FAP is minimally expressed by most healthy t...

(This article belongs to the Section Photochemistry)
  • Review
  • Open Access
29 Citations
11,008 Views
24 Pages

Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals

  • Xiaona Sun,
  • Yuxuan Wu,
  • Xingkai Wang,
  • Xin Gao and ,
  • Siqi Zhang,
  • Zhicheng Sun,
  • Ruping Liu and
  • Kuan Hu
  • + 3 authors+ 0 author

Fibroblast activation protein (FAP) is a serine protease characterized by its high expression in cancer-associated fibroblasts (CAFs) and near absence in adult normal tissues and benign lesions. This unique expression pattern positions FAP as a prosp...

(This article belongs to the Special Issue Advances in Radiopharmaceuticals for Disease Diagnoses and Therapy)
  • Review
  • Open Access
4 Citations
4,913 Views
27 Pages

Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy

  • Neda Nilforoushan,
  • Ashkan Khavaran,
  • Maierdan Palihati,
  • Yashvi Patel and ,
  • Anna O. Giarratana,
  • Jeeban Paul Das and
  • Kathleen M. Capaccione
  • + 2 authors+ 0 author

17 December 2025

Cancer-associated fibroblasts (CAFs) are an abundant and diverse cell population within tumor microenvironments of solid tumors. Multiple subtypes of CAFs, defined by molecular and functional markers, have been described in the literature. CAFs contr...

(This article belongs to the Special Issue Celebrate the 10th Anniversary of Tomography)
  • Article
  • Open Access
18 Citations
6,570 Views
18 Pages

The accurate detection of P-wave FAP (First-Arrival Picking) in seismic signals is crucial across various industrial domains, including coal and oil exploration, tunnel construction, hydraulic fracturing, and earthquake early warning systems. At pres...

(This article belongs to the Special Issue AI in Disaster, Crisis, and Emergency Management)
  • Review
  • Open Access
130 Citations
31,826 Views
22 Pages

FAPI PET/CT Imaging—An Updated Review

  • Kunal Ramesh Chandekar,
  • Arun Prashanth,
  • Sobhan Vinjamuri and
  • Rakesh Kumar

Despite revolutionizing the field of oncological imaging, Positron Emission Tomography (PET) with [18F]Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity and low sensitivity in certain tumor subtypes. Fibroblast activation...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Article
  • Open Access
6 Citations
4,656 Views
15 Pages

[68Ga]Ga-FAP-2286—Synthesis, Quality Control and Comparison with [18F]FDG PET/CT in a Patient with Suspected Cholangiocellular Carcinoma

  • Anton Amadeus Hörmann,
  • Gregor Schweighofer-Zwink,
  • Gundula Rendl,
  • Kristina Türk and ,
  • Samuel Nadeje,
  • Kristina Haas,
  • Theresa Jung,
  • Ursula Huber-Schönauer,
  • Lukas Hehenwarter and
  • Christian Pirich
  • + 6 authors+ 1 author

29 August 2024

[68Ga]Ga-FAP-2286 is a new peptide-based radiopharmaceutical for positron-emission tomography (PET) that targets fibroblast activation protein (FAP). This article describes in detail the automated synthesis of [68Ga]Ga-FAP-2286 using a commercially a...

(This article belongs to the Special Issue Past, Present and Future Radiotracer Techniques: Radiopharmaceuticals in Cancer Theranostics)
  • Review
  • Open Access
9 Citations
4,446 Views
21 Pages

Radiolabelled FAPI Radiotracers in Oncology: A Comprehensive Review of Current Diagnostic and Emerging Therapeutic Applications

  • Jolanta Czuczejko,
  • Bogdan Małkowski,
  • Jarosław Nuszkiewicz,
  • Iga Hołyńska-Iwan and ,
  • Paweł Waśniowski,
  • Katarzyna Mądra-Gackowska,
  • Wiktor Dróżdż and
  • Karolina Szewczyk-Golec
  • + 3 authors+ 0 author

2 January 2026

Background/Objectives: Fibroblast activation protein (FAP), which is abundantly expressed in cancer-associated fibroblasts (CAFs) across various epithelial malignancies, has emerged as a promising target for molecular imaging and radionuclide therapy...

(This article belongs to the Special Issue Recent Advances in the Discovery and Development of Drugs for Civilization Diseases, 2nd Edition)
  • Review
  • Open Access
456 Views
21 Pages

Tracking Active Fibroblast-Mediated Tissue Remodelling in Cardiomyopathies: Translational Insights from FAPI PET Imaging

  • Inês Fortuna,
  • Janete Santos,
  • Paula Soeiro,
  • Raquel Machado and ,
  • Ana Oliveira,
  • Jorge Pereira,
  • Giuseppe Limongelli,
  • Teresa Faria and
  • Elisabete Martins
  • + 4 authors+ 0 author

7 October 2026

Myocardial fibrosis is a major pathological component of cardiac remodelling and contributes to ventricular stiffness, impaired myocardial function, heart failure progression, and arrhythmic vulnerability across a broad spectrum of cardiomyopathies....

(This article belongs to the Special Issue Recent Advances in Molecular Imaging and Therapy)
  • Article
  • Open Access
23 Citations
5,177 Views
17 Pages

[99mTc]Tc-iFAP/SPECT Tumor Stroma Imaging: Acquisition and Analysis of Clinical Images in Six Different Cancer Entities

  • Paola Vallejo-Armenta,
  • Guillermina Ferro-Flores,
  • Clara Santos-Cuevas,
  • Francisco Osvaldo García-Pérez and ,
  • Pamela Casanova-Triviño,
  • Bayron Sandoval-Bonilla,
  • Blanca Ocampo-García,
  • Erika Azorín-Vega and
  • Myrna Luna-Gutiérrez
  • + 4 authors+ 0 author

Fibroblast activation protein (FAP) is highly expressed on the cancer-associated fibroblasts (CAF) of the tumor stroma. Recently, we reported the preclinical evaluation and clinical biokinetics of a novel 99mTc-labeled FAP inhibitor radioligand ([99m...

(This article belongs to the Special Issue In Vivo Nuclear Molecular Imaging in Drug Development and Pharmacological Research)
  • Article
  • Open Access
23 Citations
5,972 Views
14 Pages

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [68Ga]Ga-DATA5m.SA.FAPi

  • Lukas Greifenstein,
  • Carsten S. Kramer,
  • Euy Sung Moon,
  • Frank Rösch and ,
  • Andre Klega,
  • Christian Landvogt,
  • Corinna Müller and
  • Richard P. Baum
  • + 3 authors+ 0 author

14 August 2022

Radiolabeled FAPI (fibroblast activation protein inhibitors) recently gained attention as widely applicable imaging and potential therapeutic compounds targeting CAF (cancer-associated fibroblasts) or DAF (disease-associated fibroblasts in benign dis...

(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))
  • Opinion
  • Open Access
3 Citations
1,803 Views
9 Pages

FAP-Directed Imaging and Therapy in Head and Neck Cancer of Unknown Primary

  • Sophie C. Kunte,
  • Gabriel T. Sheikh,
  • Frederik L. Giesel,
  • Martin Canis and
  • Rudolf A. Werner

30 June 2025

Head and neck cancer encompasses a diverse group of malignancies arising from various anatomical subsites, e [...]

(This article belongs to the Special Issue Head and Neck Cancer: Advanced PET/CT and MRI Imaging with a Focus on Current and Emerging Molecular Theranostics)
  • Article
  • Open Access
5 Citations
4,432 Views
21 Pages

Rapid Target Binding and Cargo Release of Activatable Liposomes Bearing HER2 and FAP Single-Chain Antibody Fragments Reveal Potentials for Image-Guided Delivery to Tumors

  • Felista L. Tansi,
  • Ronny Rüger,
  • Claudia Böhm,
  • Frank Steiniger and ,
  • Martin Raasch,
  • Alexander S. Mosig,
  • Roland E. Kontermann,
  • Ulf K. Teichgräber,
  • Alfred Fahr and
  • Ingrid Hilger
  • + 5 authors+ 0 author

Liposomes represent suitable tools for the diagnosis and treatment of a variety of diseases, including cancers. To study the role of the human epidermal growth factor receptor 2 (HER2) as target in cancer imaging and image-guided deliveries, liposome...

(This article belongs to the Special Issue Nanopharmaceuticals for Image-Guided Cancer Therapy and Diagnosis)
  • Article
  • Open Access
4 Citations
6,044 Views
22 Pages

Identifying the Morphological and Molecular Features of a Cell-Based Orthotopic Pancreatic Cancer Mouse Model during Growth over Time

  • Felista L. Tansi,
  • Andrea Schrepper,
  • Michael Schwarzer,
  • Ulf Teichgräber and
  • Ingrid Hilger

Pancreatic ductal adenocarcinoma (PDAC), characterized by hypovascularity, hypoxia, and desmoplastic stroma is one of the deadliest malignancies in humans, with a 5-year survival rate of only 7%. The anatomical location of the pancreas and lack of sy...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
4 Citations
3,165 Views
14 Pages

Tumor Progression from a Fibroblast Activation Protein Perspective: Novel Diagnostic and Therapeutic Scenarios for Colorectal Cancer

  • Martina Rossetti,
  • Stefano Stanca,
  • Rossella Del Frate,
  • Francesco Bartoli and ,
  • Andrea Marciano,
  • Enrica Esposito,
  • Alessandra Fantoni,
  • Anna Paola Erba,
  • Piero Vincenzo Lippolis and
  • Pinuccia Faviana
  • + 5 authors+ 0 author

13 October 2023

In 2020, the Global Cancer Observatory estimated the incidence of colorectal cancer (CRC) at around 10.7% coupled with a mortality rate of 9.5%. The explanation for these values lies in the tumor microenvironment consisting of the extracellular matri...

(This article belongs to the Topic Advances in Gastrointestinal and Liver Disease: From Physiological Mechanisms to Clinical Practice)
  • Review
  • Open Access
20 Citations
3,952 Views
13 Pages

FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases

  • Dalia A. Lartey,
  • Lynn A. Schilder,
  • Gerben J. C. Zwezerijnen,
  • Geert R. A. M. D’Haens and ,
  • Joep Grootjans and
  • Mark Löwenberg
  • + 1 author+ 0 author

Immune-mediated inflammatory diseases (IMIDs) are characterized by chronic systemic inflammation and multi-organ involvement. Fibrosis formation in IMIDs can cause tissue destruction and subsequently organ malfunction. Fibroblast activation protein i...

(This article belongs to the Special Issue Inflammatory Bowel Diseases: New Diagnostic and Therapeutic Approaches)
  • Article
  • Open Access
6 Citations
2,825 Views
19 Pages

Objectives: Tumor heterogeneity and acquired resistance to prostate-specific membrane antigen (PSMA) radioligand therapy (PRLT) pose significant challenges to PSMA PET-based diagnosis. This study aimed to develop an Al18F-labeled FAP-targeted tracer...

(This article belongs to the Section Drug Targeting and Design)
  • Article
  • Open Access
8 Citations
4,705 Views
17 Pages

Design, Synthesis, and Biological Evaluation of a Novel [18F]AlF-H3RESCA-FAPI Radiotracer Targeting Fibroblast Activation Protein

  • Qingyu Zhang,
  • Zhoumi Hu,
  • Haitao Zhao,
  • Fuqiang Du and ,
  • Chun Lv,
  • Tukang Peng,
  • Yukai Zhang,
  • Bowu Zhang,
  • Jianjun Liu and
  • Cheng Wang
  • + 5 authors+ 0 author

19 February 2025

Background: Cancer-associated fibroblasts (CAFs) are key contributors to the tumorigenic process, with fibroblast activation protein (FAP) overexpressed on CAFs in numerous epithelial carcinomas. FAP represents a promising target for tumor imaging an...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
9 Citations
5,304 Views
13 Pages

Novel 68Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast

  • Arsyangela Verena,
  • Hsiou-Ting Kuo,
  • Helen Merkens,
  • Jutta Zeisler and ,
  • Shreya Bendre,
  • Antonio A. W. L. Wong,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 3 authors+ 0 author

16 March 2023

Compared to quinoline-based fibroblast activation protein (FAP)-targeted radiotracers, pyridine-based FAP-targeted tracers are expected to have faster pharmacokinetics due to their smaller molecular size and higher hydrophilicity, which we hypothesiz...

(This article belongs to the Special Issue Novel Imaging Probes: From Design to Applications)
  • Article
  • Open Access
3 Citations
4,020 Views
14 Pages

Synthesis and Preclinical Evaluation of Two Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeted Tracers with 2-Nal-Containing PSMA-Targeted Pharmacophore and Pyridine-Based FAP-Targeted Pharmacophore

  • Arsyangela Verena,
  • Helen Merkens,
  • Chao-Cheng Chen,
  • Devon E. Chapple and ,
  • Lei Wang,
  • Shreya Bendre,
  • Antonio A. W. L. Wong,
  • François Bénard and
  • Kuo-Shyan Lin
  • + 4 authors+ 0 author

9 February 2024

Some bispecific radiotracers have been developed to overcome the limitations of monospecific tracers and improve detection sensitivity for heterogeneous tumor lesions. Here, we aim to synthesize two bispecific tracers targeting prostate-specific memb...

(This article belongs to the Special Issue Advance in Radiochemistry)
  • Article
  • Open Access
13 Citations
5,195 Views
17 Pages

Selection and Identification of an ssDNA Aptamer for Fibroblast Activation Protein

  • Xiaomin Zhang,
  • Ge Yang,
  • Yi Zhao,
  • Xuyan Dai and ,
  • Wenjing Liu,
  • Feng Qu and
  • Yuanyu Huang
  • + 2 authors+ 0 author

9 February 2023

As a type II transmembrane serine protease, fibroblast activation protein (FAP) is specifically expressed on the surface of fibroblasts associated with a variety of epithelial-derived malignancies such as pancreatic cancer, breast cancer, and colon c...

(This article belongs to the Special Issue Current Advances in the Discovery and Development of New Therapies against Cancer)
  • Review
  • Open Access
17 Citations
9,086 Views
38 Pages

24 November 2024

The tumor microenvironment (TME) is a dynamic and complex medium that plays a central role in cancer progression, metastasis, and treatment resistance. Among the key elements of the TME, cancer-associated fibroblasts (CAFs) are particularly important...

(This article belongs to the Section Cancer Biology)
  • Review
  • Open Access
68 Citations
13,092 Views
30 Pages

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress

  • Surachet Imlimthan,
  • Euy Sung Moon,
  • Hendrik Rathke,
  • Ali Afshar-Oromieh and ,
  • Frank Rösch,
  • Axel Rominger and
  • Eleni Gourni
  • + 2 authors+ 0 author

5 October 2021

Over the past decade, the tumor microenvironment (TME) has become a new paradigm of cancer diagnosis and therapy due to its unique biological features, mainly the interconnection between cancer and stromal cells. Within the TME, cancer-associated fib...

(This article belongs to the Special Issue Forward Thinking towards Theranostic (Radio)ligands Targeting the Tumor Microenvironment (TME))
  • Review
  • Open Access
28 Citations
6,951 Views
16 Pages

Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors

  • Yixin Shi,
  • Ziren Kong,
  • Penghao Liu,
  • Guozhu Hou and ,
  • Jiaming Wu,
  • Wenbin Ma,
  • Xin Cheng and
  • Yu Wang
  • + 3 authors+ 0 author

10 May 2021

Currently, glioblastoma (GBM) is the most common malignant tumor of the central nervous system in adults. Fibroblast activation protein (FAP) is a member of the dipeptidyl peptidase family, which has catalytic activity and is engaged in protein recru...

(This article belongs to the Special Issue Molecular Biology in Glioblastoma Multiforme Treatment)
  • Article
  • Open Access
251 Views
16 Pages

Preclinical Evaluation of 177Lu-Labeled PSMA and FAP Bispecific Radioligand for Prostate Cancer

  • Ran Xue,
  • Yachao Liu,
  • Xinlin Wang,
  • Xiaojun Zhang and ,
  • Hui Wen,
  • Xiaodan Xu,
  • Shuang Geng,
  • Jingran Xie,
  • Mengchao Cui and
  • Baixuan Xu
  • + 5 authors+ 0 author

23 October 2026

Background/Objectives: During prostate cancer progression, downregulation or loss of prostate-specific membrane antigen (PSMA) expression, together with interlesional heterogeneity, may limit the efficacy of PSMA-targeted radioligand therapy. Fibrobl...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Article
  • Open Access
13 Citations
4,118 Views
12 Pages

Evaluation of Targeted Alpha Therapy Using [211At]FAPI1 in Triple-Negative Breast Cancer Xenograft Models

  • Kaori Abe,
  • Tadashi Watabe,
  • Kazuko Kaneda-Nakashima,
  • Yoshifumi Shirakami and ,
  • Yuichiro Kadonaga,
  • Sadahiro Naka,
  • Kazuhiro Ooe,
  • Atsushi Toyoshima,
  • Frederik Giesel and
  • Kenzo Shimazu
  • + 14 authors+ 9 authors

28 October 2024

Triple-negative breast cancer (TNBC) presents limited therapeutic options and is associated with poor prognosis. Early detection and the development of novel therapeutic agents are therefore imperative. Fibroblast activation protein (FAP) is a membra...

(This article belongs to the Section Molecular Oncology)
  • Review
  • Open Access
28 Citations
7,139 Views
13 Pages

FAPI PET/CT in Diagnostic and Treatment Management of Colorectal Cancer: Review of Current Research Status

  • Zhiming Cheng,
  • Shu Wang,
  • Shuoyan Xu,
  • Bulin Du and ,
  • Xuena Li and
  • Yaming Li
  • + 1 author+ 0 author

11 January 2023

FAPI PET/CT is a novel imaging tool targeting fibroblast activation protein (FAP), with high tumor uptake rate and low background noise. Therefore, the appearance of FAPI PET/CT provides a good tumor-to-background ratio between tumor and non-tumor ti...

(This article belongs to the Section Nuclear Medicine & Radiology)
  • Review
  • Open Access
27 Citations
5,726 Views
26 Pages

18 September 2023

Fibrosis is a common healing process that occurs during stress and injury in cardiovascular diseases. The evolution of fibrosis is associated with cardiovascular disease states and causes adverse effects. Fibroblast activation is responsible for the...

(This article belongs to the Section Cardiovascular Medicine)
  • Article
  • Open Access
8 Citations
3,774 Views
19 Pages

Predicting Microenvironment in CXCR4- and FAP-Positive Solid Tumors—A Pan-Cancer Machine Learning Workflow for Theranostic Target Structures

  • André Marquardt,
  • Philipp Hartrampf,
  • Philip Kollmannsberger,
  • Antonio G. Solimando and ,
  • Svenja Meierjohann,
  • Hubert Kübler,
  • Ralf Bargou,
  • Bastian Schilling,
  • Sebastian E. Serfling and
  • Markus Krebs
  • + 8 authors+ 3 authors

6 January 2023

(1) Background: C-X-C Motif Chemokine Receptor 4 (CXCR4) and Fibroblast Activation Protein Alpha (FAP) are promising theranostic targets. However, it is unclear whether CXCR4 and FAP positivity mark distinct microenvironments, especially in solid tum...

(This article belongs to the Special Issue Cancer: Updates on Imaging and Machine Learning)
  • Review
  • Open Access
42 Citations
6,420 Views
20 Pages

Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review

  • Paul Windisch,
  • Daniel R. Zwahlen,
  • Stefan A. Koerber,
  • Frederik L. Giesel and ,
  • Jürgen Debus,
  • Uwe Haberkorn and
  • Sebastian Adeberg
  • + 2 authors+ 0 author

15 September 2020

Small molecules targeting fibroblast activation protein (FAP) have emerged as a new group of tracers for positron emission tomography (PET) in 2018. The purpose of this systematic review is therefore to summarize the evidence that has been gathered t...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
5 Citations
3,676 Views
12 Pages

Preclinical Study of a Dual-Target Molecular Probe Labeled with 68Ga Targeting SSTR2 and FAP

  • Huanhuan Liu,
  • Xiaojun Zhang,
  • Yue Pan,
  • Jingfeng Zhang and ,
  • Hui Wen,
  • Cong Zhang,
  • Xiaodan Xu,
  • Guangyu Ma,
  • Ruimin Wang and
  • Jinming Zhang
  • + 5 authors+ 0 author

7 December 2024

Objective: Currently, 68Ga-labeled somatostatin analogs (SSAs) are the most commonly used imaging agents for patients with neuroendocrine tumors (NETs) in clinical practice, demonstrating good results in tumor diagnosis. For applications in peptide r...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Review
  • Open Access
18 Citations
4,131 Views
11 Pages

Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics

  • Riccardo Laudicella,
  • Alessandro Spataro,
  • Ludovica Crocè,
  • Giulia Giacoppo and ,
  • Davide Romano,
  • Valerio Davì,
  • Maria Lopes,
  • Maria Librando,
  • Antonio Nicocia and
  • Sergio Baldari
  • + 13 authors+ 8 authors

Prostate cancer (PCa) is the most frequently diagnosed cancer worldwide and the second most common cause of cancer-related deaths among men. Progress in molecular imaging has magnified its clinical management; however, an unmet clinical need involves...

(This article belongs to the Special Issue The Impact of PET/CT Imaging in Oncology)
  • Article
  • Open Access
3 Citations
3,752 Views
11 Pages

[68Ga]Ga-DOTAGA-Glu(FAPi)2 Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging

  • Julie van Krimpen Mortensen,
  • Simona Mattiussi,
  • Lars Hvass,
  • Emilie Graae Lund and ,
  • Vladimir Shalgunov,
  • Frank Roesch,
  • Umberto Maria Battisti,
  • Matthias Manfred Herth and
  • Andreas Kjaer
  • + 4 authors+ 0 author

13 September 2024

The use of fibroblast activation protein inhibitors (FAPis) for positron emission tomography (PET) imaging in cancer has garnered significant interest in recent years, yielding promising results in preclinical and clinical settings. FAP is predominan...

(This article belongs to the Special Issue Optimization of Clinical Imaging: From Diagnosis to Prognosis)
  • Review
  • Open Access
31 Citations
6,971 Views
16 Pages

The Superiority of Fibroblast Activation Protein Inhibitor (FAPI) PET/CT Versus FDG PET/CT in the Diagnosis of Various Malignancies

  • Yanzhao Dong,
  • Haiying Zhou,
  • Ahmad Alhaskawi,
  • Zewei Wang and ,
  • Jingtian Lai,
  • Chengjun Yao,
  • Zhenfeng Liu,
  • Sohaib Hasan Abdullah Ezzi,
  • Vishnu Goutham Kota and
  • Hui Lu
  • + 6 authors+ 1 author

13 February 2023

Cancer represents a major cause of death worldwide and is characterized by the uncontrolled proliferation of abnormal cells that escape immune regulation. It is now understood that cancer-associated fibroblasts (CAFs), which express specific fibrobla...

  • Article
  • Open Access
5 Citations
3,467 Views
11 Pages

Improved Healthcare Access Reduces Requirements for Surgery in Indigent IBD Patients Using Biologic Therapy: A ‘Safety-Net’ Hospital Experience

  • Phillip Gu,
  • Eric Clifford,
  • Andrew Gilman,
  • Christopher Chang and ,
  • Elizabeth Moss,
  • David I. Fudman,
  • Phillip Kilgore,
  • Urska Cvek,
  • Marjan Trutschl and
  • Moheb Boktor
  • + 7 authors+ 2 authors

Low socioeconomic status (SES) is associated with greater morbidity and increased healthcare resource utilization (HRU) in IBD. We examined whether a financial assistance program (FAP) to improve healthcare access affected outcomes and HRU in a cohor...

  • Review
  • Open Access
1 Citations
1,421 Views
15 Pages

FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies

  • Ayça Arçay Öztürk,
  • Rita Saúde-Conde,
  • Juanito Gebruers and
  • Patrick Flamen

The fibroblast activation protein (FAP) has emerged as a compelling theranostic target because it is highly expressed in the tumour microenvironment of many solid malignancies, predominantly on cancer-associated fibroblasts and, in selected tumour ty...

(This article belongs to the Section Cancer Biology and Oncology)
  • Case Report
  • Open Access
5 Citations
2,036 Views
8 Pages

7 November 2023

This case report presents a 26-year-old female patient diagnosed with fundus albipunctatus (FAP), a rare form of congenital stationary night blindness. The patient’s clinical history and retinal findings spanning 23 years are consistent with FA...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
13 Citations
5,793 Views
12 Pages

SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis

  • Xiu Luo,
  • Zhe Zhang,
  • Chao Cheng,
  • Tao Wang and ,
  • Danzhou Fang,
  • Changjing Zuo,
  • Gengbiao Yuan,
  • Rou Li and
  • Xiao Li
  • + 4 authors+ 0 author

10 March 2023

The so-far used Ga-68- or F-18-labelled tracers are of a relative short time window in differentiating tumor fibrosis. SPECT applicable imaging probe, 99mTc-HYNIC-FAPI-04, was synthesized and evaluated in tumor cells and animal models of FAP-positive...

(This article belongs to the Special Issue Molecular Imaging in Oncology: Radiopharmaceuticals for PET and SPECT 2022)
  • Article
  • Open Access
3 Citations
6,104 Views
16 Pages

Monovalent and Divalent Designs of Copper Radiotheranostics Targeting Fibroblast Activation Protein in Cancer

  • Pawan Thapa,
  • Sashi Debnath,
  • Anjan Bedi,
  • Madhuri Parashar and ,
  • Paulina Gonzalez,
  • Joshua Reus,
  • Hans Hammers and
  • Xiankai Sun
  • + 3 authors+ 0 author

15 December 2024

Background: Fibroblast activation protein (FAP)-targeted theranostic radiopharmaceuticals have shown desired tumor-to-background organ selectivity due to the ubiquitous presence of FAP within the tumor microenvironment. However, suboptimal tumor rete...

(This article belongs to the Section Cancer Drug Development)
  • Article
  • Open Access
317 Views
15 Pages

Comparative Immunohistochemical Analysis of FAP and c-MET Expression Across Renal Cell Carcinoma Subtypes: Preliminary Results and Potential Theranostic Implications

  • Lena M. Unterrainer,
  • Adrien Holzgreve,
  • Sophie C. Siegmund,
  • Magdalena Schöll and ,
  • Julia Schwenke,
  • Rudolf A. Werner,
  • Frederick Klauschen,
  • Michael Staehler and
  • Stephan T. Ledderose
  • + 4 authors+ 0 author

6 October 2026

Background: Renal cell carcinoma (RCC) comprises multiple histopathological subtypes with distinct biological characteristics and clinical behavior. Despite advances in conventional imaging, the detection of small RCC lesions or distant metastases re...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
440 Views
18 Pages

Head-to-Head Comparison of FAP Antibody Clones for Tissue Expression Analysis

  • Elena Shmakova,
  • Anna Kalinchuk,
  • Elisaveta Tsarenkova,
  • Pavel Bazhenov and ,
  • Vlada Vasilchuk,
  • Dmitry Loos and
  • Liubov Tashireva
  • + 2 authors+ 0 author

8 October 2026

Background: Fibroblast activation protein (FAP) is a promising target for cancer diagnosis and therapy, but the specificity and sensitivity of anti-FAP antibodies used for immunohistochemistry (IHC) vary considerably. A head-to-head comparison of com...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
1,685 Views
18 Pages

Modulation of Cancer-Associated Fibroblasts via the miR-624-5p/FAP Axis Drives Progression and Metastasis in Non-Small Cell Lung Cancer

  • Yan Zhao,
  • Shuman Zhen,
  • Xiaoxu Li,
  • Xiaolin Chen and ,
  • Xue Zhang,
  • Xinming Zhao and
  • Lihua Liu
  • + 2 authors+ 0 author

16 January 2026

Background: Cancer-associated fibroblasts (CAFs) are key mediators of metastatic progression in non-small cell lung cancer (NSCLC). Fibroblast activation protein (FAP) serves as the hallmark of CAF activation. However, the upstream regulation of FAP...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)

of 3